Veranstaltungsart: Webinar, CLE / CPD
- Startdatum / -uhrzeit:
- 9 November 2022, 2:00 PM ET
- Enddatum / -uhrzeit:
- 9 November 2022, 3:00 PM ET
- More Information:
- Current Trends in Today’s Pharma and Device Litigation
In addition, we will explore the emerging role of independent laboratories and how plaintiffs are using product transportation to develop new theories of causation. We will discuss the unique issues presented by these emerging trends and potential strategies to combat them.
This is Part 3 of a six-part series. Part 1, The Ebb and Flow of the Law – A Year of Drug, Medical Device, and Vaccine-Related Preemption Developments is taking place on November 7, 2022, Part 2, Ethics and E-Discovery: Lessons Learned from the Alex Jones Case and Others is taking place on November 8, 2022, Part 4, Healthcare Fraud and Abuse in a Digital World is taking place on November 9, 2022, Part 5, Warning Causation: Taxonomy and Tactics is taking place on November 10, 2022, and Part 6, MDL Trends is taking place on November 10, 2022.
CLE Information: This webinar is presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.